Sanofi unit starts Phase 3 clinical trial of rotavirus vaccine
India has the largest disease burden for rotavirus gastroenteritis in the world, according to Shantha Chief Executive Harish Iyer.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | Gastroenteritis | Gastroenterology | Pharmaceuticals | Rotavirus | Rotavirus Vaccine | Vaccines